Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rafael Amado
Deep Phenotypic Characterization of NY-ESO TCR Engineered T Cells and Tumor in Patients With Advanced Myeloma
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Related publications
Adoptive Immunotherapy With Engineered T Cells Expressing and HLA-A2 Restricted Affinity-Enhanced TCR for LAGE-1 and NY-ESO-1 in Patients With Multiple Myeloma Following Auto-SCT
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Induction of Primary NY-ESO-1 Immunity: CD8+ T Lymphocyte and Antibody Responses in Peptide-Vaccinated Patients With NY-ESO-1+ Cancers
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Regulatory T Cell Depletion Enhances Tumor Specific CD8 T-Cell Responses, Elicited by Tumor Antigen NY-ESO-1b in Hepatocellular Carcinoma Patients, in Vitro
International Journal of Oncology
Cancer Research
Oncology
Treatment of Advanced Leukemia in Mice With mRNA Engineered T Cells
Human Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Quantifying and Imaging NY-ESO-1/LAGE-1-Derived Epitopes on Tumor Cells Using High Affinity T Cell Receptors
Journal of Immunology
Allergy
Immunology
Multiepitope CD8+ T Cell Response to a NY-ESO-1 Peptide Vaccine Results in Imprecise Tumor Targeting
Journal of Clinical Investigation
Medicine
MA11.07 Expression of LAG-3 and NY-ESO-1 in Tumor Cells Is Promising Biomarker Predicting Durable Clinical Benefit of PD-1 Blockade in Advanced NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Phenotypic and Functional Properties of Tumor-Infiltrating Regulatory T Cells
Mediators of Inflammation
Immunology
Cell Biology
Nonclassical Antigen-Processing Pathways Are Required for MHC Class II-Restricted Direct Tumor Recognition by NY-ESO-1-Specific CD4+ T Cells
Cancer immunology research
Cancer Research
Immunology
